BD News Archive

2014

February

Media Release / Feb 17, 2014

Novartis expands cancer immunotherapy research program with acquisition of CoStim

Read More

January

Media Release / Jan 29, 2014

Read More
Media Release / Jan 29, 2014

Read More
Media Release / Jan 29, 2014

Novartis delivers strong sales and innovation in 2013; underlying business performance reinforces growth prospects

Read More
Media Release / Jan 27, 2014

Novartis recognized among world's most sustainable companies in Corporate Knights Global 100

Read More
Media Release / Jan 24, 2014

Novartis reports positive opinion from CHMP for Xolair® in severe form of skin disease CSU, a debilitating form of hives and chronic itch

Read More
Media Release / Jan 24, 2014

Novartis to request re-examination of serelaxin (RLX030) in acute heart failure (AHF) for conditional marketing authorization in EU

Read More
Media Release / Jan 12, 2014

Hervé Hoppenot, President of Novartis Oncology, leaves Novartis to pursue career opportunity outside of organization

Read More
2013

December

Media Release / Dec 19, 2013

Sandoz begins Phase III clinical trial for biosimilar adalimumab

Read More
Media Release / Dec 18, 2013

Sandoz receives first approval for AirFluSal® Forspiro®

Read More